Key Takeaway
You can't improve what you don't measure. GH peptide IGF-1 blood testing is the cornerstone of safe and effective growth hormone peptide therapy. Without baseline labs and regular monitoring, you're guessing about your dose, your response, and your safety.
You can't improve what you don't measure. GH peptide IGF-1 blood testing is the cornerstone of safe and effective growth hormone peptide therapy. Without baseline labs and regular monitoring, you're guessing about your dose, your response, and your safety.
Key Takeaways: - important Labs Before Starting GH Peptides - Understanding Your IGF-1 Results - Monitoring Schedule During Treatment - Common Lab Questions
This guide explains what blood work you need, when to get it, what the numbers mean, and how your provider uses this data to improve your protocol.
important Labs Before Starting GH Peptides
Before your first injection, your provider should order these baseline labs.
IGF-1 (Insulin-like Growth Factor 1): The most important marker. IGF-1 is produced by your liver in response to GH. It has a longer half-life than GH itself, making it a stable, reliable indicator of your average GH status. Your baseline IGF-1 tells your provider where you're starting from.
Fasting glucose and HbA1c: GH affects insulin sensitivity. Baseline glucose markers ensure you're safe to start and give a reference point for monitoring changes. People with prediabetes or diabetes need extra caution.
Fasting insulin: Provides a more sensitive measure of insulin resistance than glucose alone. Useful for detecting early metabolic changes.
Complete metabolic panel (CMP): Liver and kidney function, electrolytes. Ensures your organs can properly process the peptide and its metabolic effects.
"Compounding pharmacies serve a critical role in healthcare, but patients need to understand the difference between a properly regulated 503B facility and an unregulated operation. Ask about PCAB accreditation and third-party testing.") Dr. Scott Brunner, PharmD, Alliance for Pharmacy Compounding
Lipid panel: Total cholesterol, LDL, HDL, triglycerides. GH can affect lipid metabolism. Baseline levels help track changes.
Thyroid panel (TSH, free T3, free T4): GH interacts with thyroid function. Undiagnosed hypothyroidism can affect your GH peptide response and should be addressed first.
For men: Testosterone, PSA. GH and testosterone have interrelated effects. PSA should be monitored in men over 40 using any growth-promoting therapy.
For women: Estradiol, progesterone. Hormonal context affects GH peptide response and helps your provider design a full protocol.
Your can order all necessary baseline labs as part of your initial evaluation.
How Your IGF-1 Results
IGF-1 is reported in ng/mL. Reference ranges vary by age and lab, but here is the general framework.
View data table
| Category | Clinical Interest Score | Detail |
|---|---|---|
| BPC-157 | 88 | Tissue repair and gut healing |
| TB-500 | 82 | Injury recovery |
| Sermorelin | 78 | Growth hormone support |
| Ipamorelin | 75 | Anti-aging and recovery |
| GHK-Cu | 70 | Skin and tissue repair |
Free Download: Protocol Planner Track your lab results alongside your GH peptide protocol. Includes reference ranges and trending templates. Get yours free (we'll email it to you instantly. [Download Your Free Protocol Planner]
Age-adjusted normal ranges (approximate): - Age 20-30: 115-355 ng/mL - Age 30-40: 115-307 ng/mL - Age 40-50: 94-267 ng/mL - Age 50-60: 81-238 ng/mL - Age 60-70: 69-200 ng/mL
Improvement targets: Most providers aim for IGF-1 in the upper third of the normal range for your age, not above the range. Supraphysiological IGF-1 levels carry potential health risks and don't provide proportionally better benefits.
What low IGF-1 means: If your baseline IGF-1 is in the lower third or below the reference range, you likely have meaningful GH deficiency. You may benefit significantly from GH peptide therapy.
What normal IGF-1 means: Even with normal IGF-1, GH peptide therapy may improve the pulsatile pattern of GH release and enhance sleep quality, recovery, and body composition. The benefits extend beyond what a single IGF-1 number captures.
What high IGF-1 means: If your IGF-1 is already in the upper range, GH peptide therapy may not be necessary or appropriate. Chronically improved IGF-1 has been associated with increased risk of certain cancers in epidemiological studies.
Log all lab results in the to track trends over time.
Monitoring Schedule During Treatment
Once you start GH peptides, regular monitoring ensures safety and guides protocol adjustments.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →At 6-8 weeks: First follow-up IGF-1 plus fasting glucose. This confirms your peptide is working and checks for early metabolic effects. If IGF-1 hasn't increased meaningfully, your provider may adjust dosing.
At 3 months: Full panel (IGF-1, glucose, HbA1c, CMP, lipids). In-depth check at the mid-protocol point. Most dose adjustments happen based on these results.
Every 3 months thereafter: IGF-1 and metabolic markers. Ongoing monitoring for as long as you continue peptide therapy. Frequency may decrease to every 6 months once your protocol is stable.
Additional testing if indicated: - DEXA scan for body composition and bone density (every 6-12 months) - Sleep study if sleep quality doesn't improve as expected - Cardiac evaluation if you have cardiovascular risk factors - Cancer screening per age-appropriate guidelines
Your provider uses this data to fine-tune your protocol. Too-low IGF-1 response may mean dose increase. Too-high may mean dose reduction. Metabolic changes may require protocol adjustment.
Read about if you're on both therapies.
Common Lab Questions
Fasting requirements: Get blood drawn fasting (8-12 hours without food). Water is fine. Draw blood before your morning injection, not after. This gives the most accurate baseline reading.
Time of day matters: IGF-1 is relatively stable throughout the day, so exact timing is less critical than with GH itself (which fluctuates dramatically). Morning fasting draws are standard practice.
How to prepare: Stop biotin supplements 72 hours before lab draws (biotin can interfere with some immunoassays). Continue your peptide protocol as normal, just draw blood before your daily dose.
Cost of labs: Many providers include lab work in their protocol fees. If ordering independently, IGF-1 testing typically costs $50-100 through direct-to-consumer lab services. Full panels may cost $200-400 depending on included markers.
Your coordinates lab work as part of your treatment plan.
Frequently Asked Questions
Can I test my own GH levels directly?
GH itself is difficult to test because it fluctuates dramatically throughout the day. A random GH blood draw is nearly meaningless. IGF-1 is the preferred marker because it reflects your average GH status over days, not the momentary level at the time of the blood draw.
What if my IGF-1 doesn't increase on GH peptides?
Several factors can limit response: poor pituitary function (your gland may not respond to stimulation), incorrect timing (eating too close to injection), degraded peptide product, or insufficient dosing. Your provider will troubleshoot based on your specific situation.
How high should I push my IGF-1?
The goal is improvement, not maximization. Most providers target IGF-1 in the upper third of the age-adjusted normal range. Pushing beyond this provides diminishing returns with increasing risk. Higher isn't always better.
Do I need labs if I feel great on my protocol?
Yes. Feeling great doesn't guarantee your metabolic markers are optimal. Regular labs catch potential issues (blood sugar changes, excessive IGF-1 elevation) before they cause symptoms.
What's Your Next Move?
You have the information. Now let a licensed provider help you put it into action. FormBlends makes it simple) answer a few questions and get a personalized recommendation.
Sources &. References
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91(12):4792-4797. Doi:10.1210/jc.2006-1702
This content is provided for informational and educational purposes only. It isn't a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed healthcare provider with any questions about a medical condition or treatment plan.
Last updated: 2026-03-24